In biotherapeutics manufacturing, controlling size variants of therapeutic monoclonal antibodies (mAbs) is critical for ensuring product quality.
Haley Sutton
Advertisement
Haley Sutton is with Tanvex Biopharma USA, Inc. in San Diego, California.
Articles by Haley Sutton
Advertisement
Latest Updated Articles
Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC MethodPublished: June 28th 2024 | Updated:
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
